CN1104898C - 眼压降低剂 - Google Patents

眼压降低剂 Download PDF

Info

Publication number
CN1104898C
CN1104898C CN95193132A CN95193132A CN1104898C CN 1104898 C CN1104898 C CN 1104898C CN 95193132 A CN95193132 A CN 95193132A CN 95193132 A CN95193132 A CN 95193132A CN 1104898 C CN1104898 C CN 1104898C
Authority
CN
China
Prior art keywords
group
general formula
compound
lower alkyl
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN95193132A
Other languages
English (en)
Chinese (zh)
Other versions
CN1148809A (zh
Inventor
横山富久
细川常通
柳泽宏明
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sankyo Co Ltd
Original Assignee
Sankyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co Ltd filed Critical Sankyo Co Ltd
Publication of CN1148809A publication Critical patent/CN1148809A/zh
Application granted granted Critical
Publication of CN1104898C publication Critical patent/CN1104898C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Materials For Medical Uses (AREA)
CN95193132A 1994-03-16 1995-03-16 眼压降低剂 Expired - Fee Related CN1104898C (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP45404/94 1994-03-16
JP45404/1994 1994-03-16
JP4540494 1994-03-16

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB021199396A Division CN1202819C (zh) 1994-03-16 2002-05-11 眼压降低剂

Publications (2)

Publication Number Publication Date
CN1148809A CN1148809A (zh) 1997-04-30
CN1104898C true CN1104898C (zh) 2003-04-09

Family

ID=12718322

Family Applications (2)

Application Number Title Priority Date Filing Date
CN95193132A Expired - Fee Related CN1104898C (zh) 1994-03-16 1995-03-16 眼压降低剂
CNB021199396A Expired - Fee Related CN1202819C (zh) 1994-03-16 2002-05-11 眼压降低剂

Family Applications After (1)

Application Number Title Priority Date Filing Date
CNB021199396A Expired - Fee Related CN1202819C (zh) 1994-03-16 2002-05-11 眼压降低剂

Country Status (19)

Country Link
US (1) US5925664A (https=)
EP (2) EP1110551B1 (https=)
KR (1) KR100211446B1 (https=)
CN (2) CN1104898C (https=)
AT (2) ATE266402T1 (https=)
AU (1) AU684916B2 (https=)
CZ (1) CZ284395B6 (https=)
DE (2) DE69533045T2 (https=)
DK (2) DK1110551T3 (https=)
ES (2) ES2221872T3 (https=)
FI (2) FI114897B (https=)
GR (1) GR3036989T3 (https=)
HU (1) HUT74734A (https=)
MX (1) MX9604109A (https=)
NO (1) NO311068B1 (https=)
NZ (1) NZ282485A (https=)
PT (2) PT1110551E (https=)
RU (1) RU2123847C1 (https=)
WO (1) WO1995024902A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE295721T1 (de) * 1999-06-11 2005-06-15 Sankyo Co Den augendruck senkende zusammensetzung zur topischen anwendung
TWI290470B (en) 1999-12-01 2007-12-01 Sankyo Co The composition for treating glaucoma
GR20000100281A (el) * 2000-08-17 2002-05-24 Ιωαννης Ματσουκας Ανταγωνιστες του υποδοχεα της αγγεοτενσινης ιι και συνθετικες μεθοδοι για την θεραπεια της υπερτασης και καρδιοαγγειακων ασθενειων
AU2002218527A1 (en) * 2000-12-05 2002-06-18 Sankyo Company Limited Ocular tension-lowering compositions for topical administration
KR101087519B1 (ko) * 2003-04-15 2011-11-28 상꾜 가부시키가이샤 안구 내 혈관 신생성 질환의 예방 또는 치료를 위한 의약

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2549049B1 (fr) * 1983-07-13 1986-06-20 Chauvin Blache Lab Nouvelles amidines, leur procede de preparation et leur application therapeutique
CA1334092C (en) * 1986-07-11 1995-01-24 David John Carini Angiotensin ii receptor blocking imidazoles
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
ZA875052B (en) * 1986-07-11 1989-03-29 Du Pont Angiotensin ii receptor blocking imidazoles
US4820843A (en) * 1987-05-22 1989-04-11 E. I. Du Pont De Nemours And Company Tetrazole intermediates to antihypertensive compounds
US4880804A (en) * 1988-01-07 1989-11-14 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking benzimidazoles
CA1338238C (en) * 1988-01-07 1996-04-09 David John Carini Angiotensin ii receptor blocking imidazoles and combinations thereof with diuretics and nsaids
US4916129A (en) * 1989-01-19 1990-04-10 E. I. Du Pont De Nemours And Company Combination β-blocking/angiotensin II blocking antihypertensives
SG52709A1 (en) * 1989-06-30 1998-09-28 Du Pont Substituted imidazoles
WO1991015206A1 (en) * 1990-04-05 1991-10-17 E.I. Du Pont De Nemours And Company Treatment of glaucoma and ocular hypertension with imidazole angiotensin-ii receptor antagonists
US5196444A (en) * 1990-04-27 1993-03-23 Takeda Chemical Industries, Ltd. 1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylate and compositions and methods of pharmaceutical use thereof
US5126342A (en) * 1990-10-01 1992-06-30 Merck & Co., Inc. Imidazole angiotensin ii antagonists incorporating acidic functional groups
US5616599A (en) * 1991-02-21 1997-04-01 Sankyo Company, Limited Angiotensin II antagosist 1-biphenylmethylimidazole compounds and their therapeutic use
IS1756B (is) * 1991-02-21 2000-12-28 Sankyo Company Limited Hliðstæðuaðferð til framleiðslu 1-Biphenylmethylimidazole afleiða
DE4132631A1 (de) * 1991-10-01 1993-04-08 Bayer Ag Imidazolyl-propensaeurederivate
US5219856A (en) * 1992-04-06 1993-06-15 E. I. Du Pont De Nemours And Company Angiotensin-II receptor blocking, heterocycle substituted imidazoles
DK0573218T3 (da) * 1992-06-02 2001-06-18 Sankyo Co 4-carboxyimidazolderivater som angiotensin-II antagonister og deres terapeutiske anvendelse
US5310929A (en) * 1992-08-06 1994-05-10 E. I. Du Pont De Nemours And Company Prodrugs of imidazole carboxylic acids as angiotensin II receptor antagonists
RU2109736C1 (ru) * 1992-12-17 1998-04-27 Санкио Компани Лимитед Производные бифенила и способ их получения
CZ154994A3 (en) * 1993-07-02 1995-09-13 Senju Pharma Co Visual hypotensive agent
ATE300287T1 (de) * 1994-02-08 2005-08-15 Novartis Pharma Gmbh Behandlung von normaldruckglaukom mit valsartan

Also Published As

Publication number Publication date
HUT74734A (en) 1997-02-28
DE69522955T2 (de) 2002-05-29
KR970701542A (ko) 1997-04-12
FI114897B (fi) 2005-01-31
US5925664A (en) 1999-07-20
HK1000551A1 (en) 2002-04-12
NO311068B1 (no) 2001-10-08
HU9602534D0 (en) 1996-11-28
FI963645A0 (fi) 1996-09-16
CN1387846A (zh) 2003-01-01
MX9604109A (es) 1997-09-30
ES2163501T3 (es) 2002-02-01
KR100211446B1 (ko) 1999-08-02
EP1110551B1 (en) 2004-05-12
EP0795326A4 (https=) 1997-09-17
EP0795326A1 (en) 1997-09-17
AU684916B2 (en) 1998-01-08
DE69533045T2 (de) 2005-01-27
NO963854D0 (no) 1996-09-13
AU1960295A (en) 1995-10-03
FI115197B (fi) 2005-03-31
EP0795326B1 (en) 2001-09-26
CZ284395B6 (cs) 1998-11-11
PT1110551E (pt) 2004-07-30
CZ269496A3 (en) 1996-12-11
RU2123847C1 (ru) 1998-12-27
ATE266402T1 (de) 2004-05-15
CN1148809A (zh) 1997-04-30
NZ282485A (en) 1997-06-24
ATE206050T1 (de) 2001-10-15
FI963645A7 (fi) 1996-11-14
DK0795326T3 (da) 2001-11-26
EP1110551A2 (en) 2001-06-27
CN1202819C (zh) 2005-05-25
ES2221872T3 (es) 2005-01-16
DE69533045D1 (de) 2004-06-17
DK1110551T3 (da) 2004-06-07
GR3036989T3 (en) 2002-01-31
DE69522955D1 (de) 2001-10-31
EP1110551A3 (en) 2001-08-16
PT795326E (pt) 2002-01-30
FI20041236L (fi) 2004-09-24
NO963854L (no) 1996-11-14
WO1995024902A1 (en) 1995-09-21

Similar Documents

Publication Publication Date Title
TWI403510B (zh) 腎素抑制劑及其使用方法
CN1610666A (zh) 苄脒衍生物
CN1263512C (zh) 治疗青光眼用并用剂
CN1308616A (zh) 用于治疗炎性、自身免疫和呼吸疾病的依赖于vla－4的细胞结合的非肽基抑制剂
CN1921847A (zh) 氨基醇化合物
CN1104898C (zh) 眼压降低剂
CN1121398C (zh) 脂环式酰化杂环衍生物
US8202855B2 (en) Substituted beta-lactams
WO2000076543A1 (fr) Composition permettant de reduire la tension oculaire et destinee a l'administration topique
JP2826077B2 (ja) 眼圧低下剤
CA2185524C (en) Ocular tension depressant
CN1628099A (zh) 水溶性苯基甘氨酸衍生物
CN1307992C (zh) 含四唑衍生物的滴眼剂
HK1000551B (en) Ocular tension depressant
HK1035485B (en) Ocular tension lowering agent
HK1035485A1 (en) Ocular tension lowering agent
JP2001055329A (ja) 局所投与用眼圧低下組成物
AU2004200751A1 (en) Combined agents for treatment of glaucoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20030409

Termination date: 20100316